These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35017690)

  • 21. Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    Lin DY; Du Y; Xu Y; Paritala S; Donahue M; Maloney P
    N Engl J Med; 2024 Jun; 390(22):2124-2127. PubMed ID: 38810167
    [No Abstract]   [Full Text] [Related]  

  • 22. The overlooked superpower of mRNA vaccines.
    Wadman M
    Science; 2021 Jul; 373(6554):479. PubMed ID: 34326217
    [No Abstract]   [Full Text] [Related]  

  • 23. A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine.
    Messali S; Bertelli A; Campisi G; Zani A; Ciccozzi M; Caruso A; Caccuri F
    J Med Virol; 2021 Dec; 93(12):6468-6470. PubMed ID: 34329486
    [No Abstract]   [Full Text] [Related]  

  • 24. Could new COVID variants undermine vaccines? Labs scramble to find out.
    Callaway E
    Nature; 2021 Jan; 589(7841):177-178. PubMed ID: 33432212
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immune memory against SARS-CoV-2: Antibodies against the initial infection and memory B cells for the future ones].
    Reynaud CA; Weill JC; Chappert P; Mahévas M
    Med Sci (Paris); 2021; 37(8-9):722-725. PubMed ID: 34346865
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
    Yue L; Zhou J; Zhou Y; Yang X; Xie T; Yang M; Zhao H; Zhao Y; Yang T; Li H; Xiang H; Wang J; Lu S; Liu H; Zhao H; Wei X; Zhang Y; Xie Z
    Emerg Microbes Infect; 2021 Dec; 10(1):2125-2127. PubMed ID: 34666622
    [No Abstract]   [Full Text] [Related]  

  • 27. Heavily mutated Omicron variant puts scientists on alert.
    Callaway E
    Nature; 2021 Dec; 600(7887):21. PubMed ID: 34824381
    [No Abstract]   [Full Text] [Related]  

  • 28. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.
    Liu J; Liu Y; Xia H; Zou J; Weaver SC; Swanson KA; Cai H; Cutler M; Cooper D; Muik A; Jansen KU; Sahin U; Xie X; Dormitzer PR; Shi PY
    Nature; 2021 Aug; 596(7871):273-275. PubMed ID: 34111888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing Immunity Testing for SARS-CoV-2 and Other Novel Vaccines-Correlates of Immunogenicity Parameters with Protection.
    Vajo Z
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging plasticity of SARS-CoV-2.
    McCormick KD; Jacobs JL; Mellors JW
    Science; 2021 Mar; 371(6536):1306-1308. PubMed ID: 33766871
    [No Abstract]   [Full Text] [Related]  

  • 31. New Omicron begins to take over, despite late start.
    Wadman M
    Science; 2022 Feb; 375(6580):480-481. PubMed ID: 35113702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines.
    Zhao X; Zhang R; Qiao S; Wang X; Zhang W; Ruan W; Dai L; Han P; Gao GF
    N Engl J Med; 2022 Jul; 387(3):277-280. PubMed ID: 35793198
    [No Abstract]   [Full Text] [Related]  

  • 33. How bad is Omicron? What scientists know so far.
    Callaway E; Ledford H
    Nature; 2021 Dec; 600(7888):197-199. PubMed ID: 34857948
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19: Significance of antibodies.
    Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
    Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    Edara VV; Pinsky BA; Suthar MS; Lai L; Davis-Gardner ME; Floyd K; Flowers MW; Wrammert J; Hussaini L; Ciric CR; Bechnak S; Stephens K; Graham BS; Bayat Mokhtari E; Mudvari P; Boritz E; Creanga A; Pegu A; Derrien-Colemyn A; Henry AR; Gagne M; Douek DC; Sahoo MK; Sibai M; Solis D; Webby RJ; Jeevan T; Fabrizio TP
    N Engl J Med; 2021 Aug; 385(7):664-666. PubMed ID: 34233096
    [No Abstract]   [Full Text] [Related]  

  • 36. Neutralizing antibody levels and cellular immune response against Omicron variant in pregnant women vaccinated with mRNA and inactivated SARS-CoV-2 vaccines.
    Kalafat E; Talay ZG; Demirci O; Ayaz R; Çelik E; Can F;
    Ultrasound Obstet Gynecol; 2024 May; 63(5):699-700. PubMed ID: 38011582
    [No Abstract]   [Full Text] [Related]  

  • 37. Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.
    Li D; Luan N; Li J; Zhao H; Zhang Y; Long R; Jiang G; Fan S; Xu X; Cao H; Wang Y; Liao Y; Wang L; Liu L; Liu C; Li Q
    Emerg Microbes Infect; 2021 Dec; 10(1):2194-2198. PubMed ID: 34736354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Audio Interview: Antibody Responses to Natural Infection and Vaccination.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Apr; 384(14):e65. PubMed ID: 33826826
    [No Abstract]   [Full Text] [Related]  

  • 39. Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Sep; 385(12):e48. PubMed ID: 34525292
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.
    Choi A; Koch M; Wu K; Dixon G; Oestreicher J; Legault H; Stewart-Jones GBE; Colpitts T; Pajon R; Bennett H; Carfi A; Edwards DK
    J Virol; 2021 Nov; 95(23):e0131321. PubMed ID: 34549975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.